Catalyst Capital Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-165	Closed	-$2K	–	408
2016 Q2	$2K	Hold	165	–	–	﹤0.01%	341
2016 Q1	$2K	Buy	+165	New	+$2K	﹤0.01%	357